task
stringlengths 12
101
| input
stringlengths 0
88.4k
| output
stringlengths 1
139k
| options
sequence | pageTitle
stringlengths 0
1.11k
| outputColName
stringlengths 1
1.13k
| url
stringlengths 14
440
| wdcFile
stringlengths 66
76
|
|---|---|---|---|---|---|---|---|
a04e11a7_etical_Listing_of_Publications__Type | [Title] Are Foreign Banks Out-Competing U.S. Banks in the U.S. Market? [Type] | Economics Working Paper | [] | OCC: Alphabetical Listing of Publications | Type | http://occ.treas.gov/publications/alphabetical-listing/index-alphabetical-listing.html | 39/1438042989126.22_20150728002309-00322-ip-10-236-191-2_176770376_2.json |
a04e11a7_etical_Listing_of_Publications__Type | [Title] Asset Commonality and Systemic Risk Among Large Banks in the United States [Type] | Economics Working Paper | [] | OCC: Alphabetical Listing of Publications | Type | http://occ.treas.gov/publications/alphabetical-listing/index-alphabetical-listing.html | 39/1438042989126.22_20150728002309-00322-ip-10-236-191-2_176770376_2.json |
a04e11a7_etical_Listing_of_Publications__Type | [Title] Asset Management [Type] | Comptroller's Handbook | [] | OCC: Alphabetical Listing of Publications | Type | http://occ.treas.gov/publications/alphabetical-listing/index-alphabetical-listing.html | 39/1438042989126.22_20150728002309-00322-ip-10-236-191-2_176770376_2.json |
a04e11a7_etical_Listing_of_Publications__Type | [Title] Asset Management Operations and Controls [Type] | Comptroller's Handbook | [] | OCC: Alphabetical Listing of Publications | Type | http://occ.treas.gov/publications/alphabetical-listing/index-alphabetical-listing.html | 39/1438042989126.22_20150728002309-00322-ip-10-236-191-2_176770376_2.json |
a04e11a7_etical_Listing_of_Publications__Type | [Title] Asset Securitization [Type] | Comptroller's Handbook | [] | OCC: Alphabetical Listing of Publications | Type | http://occ.treas.gov/publications/alphabetical-listing/index-alphabetical-listing.html | 39/1438042989126.22_20150728002309-00322-ip-10-236-191-2_176770376_2.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Forums [Leader] Yes [Co-Leader] Yes [Third] Yes [User Control] Yes [Manager] Yes [Treasurer] | Yes | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Armoury [Leader] Yes [Co-Leader] Yes [Third] Yes [User Control] Yes [Manager] No [Treasurer] | Yes | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Applications [Leader] Yes [Co-Leader] Yes [Third] Yes [User Control] Yes [Manager] No [Treasurer] | Yes | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Change Announcement [Leader] Yes [Co-Leader] Yes [Third] Yes [User Control] Yes [Manager] No [Treasurer] | Yes | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Change Description [Leader] Yes [Co-Leader] Yes [Third] Yes [User Control] Yes [Manager] No [Treasurer] | Yes | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Organized Crimes [Leader] Yes [Co-Leader] Yes [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Change Statement [Leader] Yes [Co-Leader] Yes [Third] Yes [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Give to User [Leader] Yes [Co-Leader] Yes [Third] No [User Control] No [Manager] No [Treasurer] | Yes | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Send Newsletters [Leader] Yes [Co-Leader] Yes [Third] No [User Control] No [Manager] Yes [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Change Co-Leader [Leader] Yes [Co-Leader] Yes [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Upgrades [Leader] Yes [Co-Leader] Yes [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] War Functions [Leader] Yes [Co-Leader] Yes [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Change Leader [Leader] Yes [Co-Leader] No [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Change Name [Leader] Yes [Co-Leader] No [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Change Tag [Leader] Yes [Co-Leader] No [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Faction Image [Leader] Yes [Co-Leader] No [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Managers [Leader] Yes [Co-Leader] No [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Delete Faction [Leader] Yes [Co-Leader] No [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
77d87d12_fficial_help_and_support_guide__Treasurer | [0] Pay Day [Leader] Yes [Co-Leader] No [Third] No [User Control] No [Manager] No [Treasurer] | No | [
[
"Y",
"e",
"s"
],
[
"N",
"o"
]
] | Torn City Factions - Torncity WIKI - The official help and support guide | Treasurer | http://www.torn.com/wiki/index.php?title=Factions&oldid=2493 | 39/1438042989126.22_20150728002309-00206-ip-10-236-191-2_778360330_14.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | Someone or something interrupts you when you are taking your medicine. [Possible solutions] | Ask the person to wait a minute while you take your medicine. Don't put your medicine down. Keep it in your hand or on your lap. This way it remains in front of you, and you are less likely to forget about it. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You make a change in what you usually do every day. [Possible solutions] | Think about how the change will affect your medicine schedule. Make sure there is still a convenient time to take your medicine. Always take your quick-relief medicine with you. Ask a friend to remind you. Place a reminder someplace where you will see it, such as in your car or on a house key. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | Something happens during the day so that you can't take it. [Possible solutions] | Always keep extra medicines in your car or on your person. Talk to your doctor about what you should do if you miss a dose. Can you make it up? | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You are out of medicine. [Possible solutions] | Talk with your doctor or pharmacist about how long your medicine will last, and use a calendar or day planner to remind yourself to get new medicine. Get your refill before your supply runs out. Ask your pharmacist to give you a phone call a few days before you need to refill your prescription. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You feel good, so you don't take your medicine. [Possible solutions] | Remember that you feel good because you are taking the medicine. Make it a habit to take your medicine at the same time that you do one of your daily activities, such as when you eat or when you brush your teeth. Ask a family member or friend to remind you. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You take many medicines, and you are not sure what to take or when to take it. [Possible solutions] | Talk to your doctor or pharmacist and write down what he or she tells you, or ask that a calendar be set up for you. Use color-coding or "personalize" your medicine in a way that will help you take the right medicine at the right time. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You just forget. [Possible solutions] | Put a sign in the bathroom or on the refrigerator as a reminder. Make it a habit to take your medicine at the same time that you do one of your daily activities, such as when you eat or when you brush your teeth. Ask a family member or friend to remind you. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You don't think the medicine is working. [Possible solutions] | Remember that some medicines do not help immediately but take time. Ask your doctor about tracking your peak expiratory flow . You may not notice a difference when taking your medicine, but your lung function may be better. Talk to your doctor. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You are having difficulty using an inhaler or don't know how to use it. [Possible solutions] | Get instruction on how to use an inhaler. Use a spacer with a metered-dose inhaler. Ask your doctor about medicines that do not require an inhaler. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You have side effects or are worried about having them. [Possible solutions] | Talk to your doctor about side effects you are experiencing or that you worry about. You may be able to try another medicine. If an upset stomach is a problem, ask your doctor if you can take the medicine with a meal. Remember that corticosteroid medicines are not the same as steroids that athletes sometimes abuse to increase their performances or the size of their muscles (anabolic steroids). | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | You may not be able to afford the medicines and medical care that is needed to treat asthma. [Possible solutions] | Get in touch with social services or religious groups about possible help. Get in touch with Medicaid, a government program that may be able to help you afford medicine and medical treatment. Talk to your doctor. He or she may have samples you can use. Contact the drug company or ask your doctor to do this. Some drug companies have programs that help people get medicine if they cannot afford it. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
a431e5ec__Obstacles_to_Taking_Medicines_es_and_some_possible_solutions_Possible_solutions | Your mood or feelings may make it difficult to take the medicine. [Possible solutions] | Have others remind you or gently encourage you to take the medicine. See your doctor. | [] | Asthma: Overcoming Obstacles to Taking Medicines | Possible solutions | http://www.ghc.org/kbase/topic.jhtml?docId=hw162177&secId=hw162177-sec | 39/1438042989126.22_20150728002309-00282-ip-10-236-191-2_473559110_2.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Identity [Comments] For master, working seed and final lots [New TB vaccines *] Multiplex PCR, sequencing [Traditional BCG vaccine **] | Microbiologic methods | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Safety [Comments] For bulk and/or final lots [New TB vaccines *] Tests for attenuation, persistence, lack of reversion to virulence [Traditional BCG vaccine **] | General safety test in mice and guinea pigs | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Safety [Comments] Meet GMO Standards [New TB vaccines *] Evidence for lack of shedding of live organisms in animals [Traditional BCG vaccine **] | NA | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Freedom from virulent Mtb [Comments] For master, working seed, bulk and/or final lots [New TB vaccines *] Multiplex PCR for live vaccine identity and animal safety studies [Traditional BCG vaccine **] | Guinea pig assay | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Antibiotic sensitivity [Comments] Evidence of susceptibility to first line drugs for TB; removal of antibiotic resistance selection markers [New TB vaccines *] MGIT analyses (liquid culture) [Traditional BCG vaccine **] | Solid media culture analyses | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Viability [Comments] For bulk and final lots [New TB vaccines *] ATP assay live/dead ratio [Traditional BCG vaccine **] | Solid media culture | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Potency [Comments] For bulk and final lots [New TB vaccines *] Immune-biological assay (to be defined) [Traditional BCG vaccine **] | Viability | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Stability [Comments] For bulk and final lots [New TB vaccines *] Immune-biological assay (to be defined) [Traditional BCG vaccine **] | Viability/Moisture. Thermal & real time stability. Intradermal skin test in guinea pigs | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Toxicology [Comments] For investigational lots [New TB vaccines *] Immune-relevant toxicology test (to be defined) [Traditional BCG vaccine **] | Necropsy analyses in rabbits | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Lot release tests [Comments] New methods may include fermentation process and synthetic media used to culture mycobacteria [New TB vaccines *] Tests for residual contaminants from fermentation [Traditional BCG vaccine **] | Evidence for no TSA—containing culture media | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Preclinical studies [Comments] To assess safety, immunogenicity & efficacy in animal models [New TB vaccines *] Survival in animal models of immunosuppression. Protection in guinea pigs and/or mice. Safety studies in NHP, (for live attenuated Mtb vaccines). Identification of immunological markers [Traditional BCG vaccine **] | NA | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
fd323523_1__Introduction__Traditional_BCG_vaccine___ | [Test] Validation of facilities [Comments] Manufacturing facilities for live TB vaccines [New TB vaccines *] PCR of individual products and cleaning, validation when campaigning products other than TB vaccines; Certain live attenuated vaccines may require dedicated facilities [Traditional BCG vaccine **] | Dedicated facilities, equipment and staff | [] | 1. Introduction | Traditional BCG vaccine ** | http://www.mdpi.com/2076-393X/1/2/120/xml | 39/1438042989126.22_20150728002309-00293-ip-10-236-191-2_580842022_0.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 174 – 176 [Length] 3 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined beta strands within the protein sequence.More...Beta strandi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 177 – 179 [Length] 3 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined hydrogen-bonded turns within the protein sequence. These elements correspond to the DSSP secondary structure code ‘T’.More...Turni | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 180 – 182 [Length] 3 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined beta strands within the protein sequence.More...Beta strandi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 188 – 197 [Length] 10 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined helical regions within the protein sequence.More...Helixi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 200 – 204 [Length] 5 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined beta strands within the protein sequence.More...Beta strandi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 206 – 213 [Length] 8 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined beta strands within the protein sequence.More...Beta strandi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 215 – 221 [Length] 7 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined beta strands within the protein sequence.More...Beta strandi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 236 – 248 [Length] 13 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined helical regions within the protein sequence.More...Helixi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 253 – 255 [Length] 3 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined beta strands within the protein sequence.More...Beta strandi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 258 – 262 [Length] 5 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined beta strands within the protein sequence.More...Beta strandi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 263 – 274 [Length] 12 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined helical regions within the protein sequence.More...Helixi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 279 – 287 [Length] 9 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined helical regions within the protein sequence.More...Helixi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
d44d45ca_atase_2___Homo_sapiens__Human___Feature_key | [Position(s)] 305 – 311 [Length] 7 [Description] Combined sources Manually validated information inferred from a combination of experimental and computational evidence. More… Manual assertion inferred from combination of experimental and computational evidencei PDB:1M3G [Feature key] | Is used to indicate the positions of experimentally determined helical regions within the protein sequence.More...Helixi | [] | DUSP2 - Dual specificity protein phosphatase 2 - Homo sapiens (Human) | Feature key | http://www.uniprot.org/uniprot/Q05923 | 39/1438043062723.96_20150728002422-00137-ip-10-236-191-2_807377956_11.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] actionPrefix [Type] string [Description] the prefix to the IDs of the actions. [Defined By] | CWidget | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] controller [Type] CController [Description] the controller that this widget belongs to. [Defined By] | CWidget | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] cssFile [Type] mixed [Description] the CSS file used for the widget. [Defined By] | CMarkdown | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] id [Type] string [Description] id of the widget. [Defined By] | CWidget | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] isFilter [Type] boolean [Description] whether this widget is used as a filter. [Defined By] | CFilterWidget | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] markdownParser [Description] Returns the markdown parser instance. [Defined By] | CMarkdown | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] owner [Type] CBaseController [Description] owner/creator of this widget. [Defined By] | CWidget | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] purifyOutput [Type] boolean [Description] whether to use CHtmlPurifier to purify the generated HTML code. [Defined By] | CMarkdown | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] stopAction [Type] boolean [Description] whether to stop the action execution when this widget is used as a filter. [Defined By] | CFilterWidget | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
3750771f__Reference___Yii_PHP_Framework__Defined_By | [Property] viewPath [Type] string [Description] Returns the directory containing the view files for this widget. [Defined By] | CWidget | [
[
"C",
"W",
"i",
"d",
"g",
"e",
"t"
],
[
"C",
"M",
"a",
"r",
"k",
"d",
"o",
"w",
"n"
],
[
"C",
"F",
"i",
"l",
"t",
"e",
"r",
"W",
"i",
"d",
"g",
"e",
"t"
]
] | CMarkdown | Class Reference | Yii PHP Framework | Defined By | http://www.yiiframework.com/doc/api/1.0/CMarkdown | 39/1438042988305.14_20150728002308-00172-ip-10-236-191-2_857328751_1.json |
0539fc11_ions_and_Sponsoring_Cosplayers__Membership_Level | [Standard] 5 [Celestial] 50 [Membership Level] | Number of Photos per Costume | [] | American Cosplay Paradise - Donations and Sponsoring Cosplayers | Membership Level | http://www.acparadise.com/acp/donations.php?cosplayerid=44208 | 39/1438043062723.96_20150728002422-00027-ip-10-236-191-2_271500652_0.json |
0539fc11_ions_and_Sponsoring_Cosplayers__Membership_Level | [Standard] 25 [Celestial] 100 [Membership Level] | Number of Unsorted Photos Allowed | [] | American Cosplay Paradise - Donations and Sponsoring Cosplayers | Membership Level | http://www.acparadise.com/acp/donations.php?cosplayerid=44208 | 39/1438043062723.96_20150728002422-00027-ip-10-236-191-2_271500652_0.json |
0539fc11_ions_and_Sponsoring_Cosplayers__Membership_Level | [Standard] Original costumes, Non-Official Variations, Props [Celestial] No Restrictions [Membership Level] | Costume Restrictions / Not Allowed | [] | American Cosplay Paradise - Donations and Sponsoring Cosplayers | Membership Level | http://www.acparadise.com/acp/donations.php?cosplayerid=44208 | 39/1438043062723.96_20150728002422-00027-ip-10-236-191-2_271500652_0.json |
0539fc11_ions_and_Sponsoring_Cosplayers__Membership_Level | [Standard] None [Celestial] Can mark costumes for sale Costumes for sale show up in search engine Can list commissions done for other people [Membership Level] | Seller Features | [] | American Cosplay Paradise - Donations and Sponsoring Cosplayers | Membership Level | http://www.acparadise.com/acp/donations.php?cosplayerid=44208 | 39/1438043062723.96_20150728002422-00027-ip-10-236-191-2_271500652_0.json |
0539fc11_ions_and_Sponsoring_Cosplayers__Membership_Level | [Standard] None [Celestial] http://www.acparadise.com/loves/(NAME HERE) [Membership Level] | Custom Cosplayer URL | [] | American Cosplay Paradise - Donations and Sponsoring Cosplayers | Membership Level | http://www.acparadise.com/acp/donations.php?cosplayerid=44208 | 39/1438043062723.96_20150728002422-00027-ip-10-236-191-2_271500652_0.json |
0539fc11_ions_and_Sponsoring_Cosplayers__Membership_Level | [Standard] None [Celestial] Less advertisements on cosplayer page Hit counters and statistics for photos and costumes Custom views for Cosplayer Page (Sort by most views, most comments, etc) VIP Section for Cosplayer Page - Add members to your VIP club, and you can post photos that are VIP only, and also send exclusive messages Construction Section for Costume Photos - Special section dedicated to construction or in-progress photos of your costumes. Enhanced Convention History Section and ability to post con reports Priority access for cosplay-related industry events [Membership Level] | Other Features | [] | American Cosplay Paradise - Donations and Sponsoring Cosplayers | Membership Level | http://www.acparadise.com/acp/donations.php?cosplayerid=44208 | 39/1438043062723.96_20150728002422-00027-ip-10-236-191-2_271500652_0.json |
0539fc11_ions_and_Sponsoring_Cosplayers__Membership_Level | [Standard] Free [Celestial] $20.00 (ONE TIME ONLY, NO ANNUAL FEE) [Membership Level] | Cost | [] | American Cosplay Paradise - Donations and Sponsoring Cosplayers | Membership Level | http://www.acparadise.com/acp/donations.php?cosplayerid=44208 | 39/1438043062723.96_20150728002422-00027-ip-10-236-191-2_271500652_0.json |
78d97f2a__Effective_Health_Care_Program_gth_of_evidence_rating_domains_Domain_Name | [Domain Type] Required This domain reflects the degree to which included studies for a given outcome have high likelihood of protection against bias (i.e., good internal validity), assessed through two main elements: Study design: Whether included studies are RCTs or other designs such as nonexperimental or observational studies. Study conduct: Considers aggregation of ratings of risk of bias of the individual studies under consideration. [Domain Score and Application] Score as one of three levels, separately by type of study design: Low level of study limitations Medium level of study limitations High level of study limitations [Domain Name] | Study limitations | [] | Radiotherapy Treatments for Head and Neck Cancer: Update - Research Protocol | AHRQ Effective Health Care Program | Domain Name | http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1852 | 39/1438042988305.14_20150728002308-00279-ip-10-236-191-2_82409058_0.json |
78d97f2a__Effective_Health_Care_Program_gth_of_evidence_rating_domains_Domain_Name | [Domain Type] Required Directness relates to: Whether evidence links interventions directly to a health outcome of specific importance for the review, and Whether the comparisons are based on head-to-head studies. The EPC should specify the comparison and outcome for which the SOE grade applies. Evidence may be indirect in several situations such as: The outcome being graded is considered intermediate (i.e., laboratory test results) in a review that is focused on clinical health outcomes (i.e., morbidity, mortality). Data do not come from head-to-head comparisons but rather from two or more bodies of evidence to compare interventions A and B – e.g., studies of A vs. placebo and B vs. placebo, or studies of A vs. C and B vs. C but not direct studies of A vs. B. Data are available only for proxy respondents (e.g., from family members or nurses) instead of directly from patients. Indirectness always implies that more than one body of evidence is required to link interventions to the most important health outcome. [Domain Score and Application] Score as one of two levels: Direct Indirect If the domain score is indirect, the EPC should specify what type of indirectness accounts for the rating. [Domain Name] | Directness | [] | Radiotherapy Treatments for Head and Neck Cancer: Update - Research Protocol | AHRQ Effective Health Care Program | Domain Name | http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1852 | 39/1438042988305.14_20150728002308-00279-ip-10-236-191-2_82409058_0.json |
78d97f2a__Effective_Health_Care_Program_gth_of_evidence_rating_domains_Domain_Name | [Domain Type] Required Consistency is the degree to which included studies find either the same direction or similar magnitude of effect. The EPC can assess this through two main elements: Direction of effect: Effect sizes have the same sign (that is, are on the same side of no effect or a minimally important difference [MID]). Magnitude of effect: The range of effect sizes is similar. The EPC may consider the overlap of CIs when making this evaluation. The importance of direction vs. magnitude of effect will depend on the key question and EPC judgments. [Domain Score and Application] Score as one of three levels: Consistent Inconsistent Unknown (e.g., single study) Single-study evidence bases (including mega-trials) cannot be judged with respect to consistency. In that instance, use “Consistency unknown (single study).” [Domain Name] | Consistency | [] | Radiotherapy Treatments for Head and Neck Cancer: Update - Research Protocol | AHRQ Effective Health Care Program | Domain Name | http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1852 | 39/1438042988305.14_20150728002308-00279-ip-10-236-191-2_82409058_0.json |
78d97f2a__Effective_Health_Care_Program_gth_of_evidence_rating_domains_Domain_Name | [Domain Type] Required Precision is the degree of certainty surrounding an effect estimate with respect to a given outcome, based on the sufficiency of sample size and number of events. Several caveats must be considered in determining the precision of a body of evidence. A body of evidence will generally be imprecise if the optimal information size (OIS) is not met. OIS refers to the minimum number of patients (and events when assessing dichotomous outcomes) needed for an evidence base to be considered adequately powered. If an EPC performed a meta-analysis, then it may also consider whether the CI crossed a threshold for an MID. If meta-analysis is infeasible or inappropriate, the EPC may consider the narrowness of the range of CIs or the significance level of p-values in the individual studies in the evidence base. [Domain Score and Application] Score as one of two levels: Precise Imprecise A precise estimate is one that would allow users to reach a clinically useful conclusion (e.g., treatment A is more effective than treatment B). [Domain Name] | Precision | [] | Radiotherapy Treatments for Head and Neck Cancer: Update - Research Protocol | AHRQ Effective Health Care Program | Domain Name | http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1852 | 39/1438042988305.14_20150728002308-00279-ip-10-236-191-2_82409058_0.json |
78d97f2a__Effective_Health_Care_Program_gth_of_evidence_rating_domains_Domain_Name | [Domain Type] Required Reporting bias results from selectively publishing or reporting research findings bases on the favorability of direction or magnitude of effect. It includes: Study publication bias (i.e., nonreporting of the full study) Selective outcome reporting bias (i.e., nonreporting or incomplete reporting of unplanned outcomes) Selective analysis reporting bias (i.e., reporting of one or more favorable analyses for a given outcome while not reporting other, less favorable analyses. Assessment of reporting bias for individual studies depends on many factors including availability of study protocols, unpublished study documents, and patient-level data. Detecting such bias is likely with access to all relevant documentation and data pertaining to a journal publication, but such access is rare. Because methods to detect reporting bias in observational studies are less certain, this guidance does not require EPCs to assess it for such studies. [Domain Score and Application] Score as one of two levels: Suspected Undetected Reporting bias is suspected when: Testing for funnel plot asymmetry demonstrates a substantial likelihood of bias, and/or A qualitative assessment suggests the likelihood of missing studies, analyses, or outcomes data that may alter the conclusions from the reported evidence. Undetected reporting bias includes all alternative scenarios. [Domain Name] | Reporting bias | [] | Radiotherapy Treatments for Head and Neck Cancer: Update - Research Protocol | AHRQ Effective Health Care Program | Domain Name | http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1852 | 39/1438042988305.14_20150728002308-00279-ip-10-236-191-2_82409058_0.json |
78d97f2a__Effective_Health_Care_Program_gth_of_evidence_rating_domains_Domain_Name | [Domain Type] Optional This association, either across or within studies, refers to a pattern of a larger effect with greater exposure (dose, duration, adherence) [Domain Score and Application] This domain should be considered when studies in the evidence base have noted levels of exposure. Score as one of two levels: Present: Dose-response pattern observed. Undetected: No dose-response pattern observed (dose-response relationship not present or could not be determined). [Domain Name] | Dose-response association | [] | Radiotherapy Treatments for Head and Neck Cancer: Update - Research Protocol | AHRQ Effective Health Care Program | Domain Name | http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1852 | 39/1438042988305.14_20150728002308-00279-ip-10-236-191-2_82409058_0.json |
78d97f2a__Effective_Health_Care_Program_gth_of_evidence_rating_domains_Domain_Name | [Domain Type] Optional Occasionally, in an observational study, plausible confounding would work in the direction opposite that of the observed effect. Had these confounders not been present, the observed effect would have been even larger that the one observed. [Domain Score and Application] This domain should be considered when plausible confounding exists that would decrease the observed effect. Score as one of two levels: Present: Confounding factors that would decrease the observed effect may be present and have not been controlled for. Absent: Confounding factors that would decrease the observed effect are not likely to be present or have been controlled for. [Domain Name] | Plausible confounding that would decrease observed effect | [] | Radiotherapy Treatments for Head and Neck Cancer: Update - Research Protocol | AHRQ Effective Health Care Program | Domain Name | http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1852 | 39/1438042988305.14_20150728002308-00279-ip-10-236-191-2_82409058_0.json |
78d97f2a__Effective_Health_Care_Program_gth_of_evidence_rating_domains_Domain_Name | [Domain Type] Optional Strength of association refers to the likelihood that the observed effect is large enough that it cannot have occurred solely as a result of bias from potential confounding factors. [Domain Score and Application] This additional domain should be considered when the effect size is particularly large. Score as one of two levels: Strong: Large effect size that is unlikely to have occurred in the absence of a true effect of the intervention Weak: Small enough effect size that it could have occurred solely as a result of bias from confounding factors. [Domain Name] | Strength of association (magnitude of effect) | [] | Radiotherapy Treatments for Head and Neck Cancer: Update - Research Protocol | AHRQ Effective Health Care Program | Domain Name | http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1852 | 39/1438042988305.14_20150728002308-00279-ip-10-236-191-2_82409058_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Athletics [Position Players] Excellent [Starters] Above Average [Bullpen] | Above Average | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Braves [Position Players] Excellent [Starters] Above Average [Bullpen] | Excellent | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Cardinals [Position Players] Excellent [Starters] Excellent [Bullpen] | Above Average | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Dodgers [Position Players] Excellent [Starters] Excellent [Bullpen] | Above Average | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Indians [Position Players] Above Average [Starters] Above Average [Bullpen] | Average | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Pirates [Position Players] Excellent [Starters] Average [Bullpen] | Excellent | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Rays [Position Players] Excellent [Starters] Average [Bullpen] | Average | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Red Sox [Position Players] Excellent [Starters] Above Average [Bullpen] | Average | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Reds [Position Players] Excellent [Starters] Excellent [Bullpen] | Above Average | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
c69f3c93_ntenders___Disciples_of_Uecker__Bullpen | [Team] Tigers [Position Players] Excellent [Starters] Excellent [Bullpen] | Average | [
[
"A",
"b",
"o",
"v",
"e",
" ",
"A",
"v",
"e",
"r",
"a",
"g",
"e"
],
[
"E",
"x",
"c",
"e",
"l",
"l",
"e",
"n",
"t"
],
[
"A",
"v",
"e",
"r",
"a",
"g",
"e"
]
] | The Brewers Rotation, and The Contenders | Disciples of Uecker | Bullpen | http://disciplesofuecker.com/the-brewers-rotation-and-the-contenders/19110 | 39/1438042988305.14_20150728002308-00216-ip-10-236-191-2_75972200_0.json |
d421d4e2_ala_D__Harris_Attorney_General__Class | [Class Code] C152 [Class] | Analysis of Explosives | [] | CCI All Courses | State of California - Department of Justice - Kamala D. Harris Attorney General | Class | https://www.oag.ca.gov/cci/all-courses?order=title&sort=asc | 39/1438042989126.22_20150728002309-00292-ip-10-236-191-2_913022365_0.json |
d421d4e2_ala_D__Harris_Attorney_General__Class | [Class Code] C452 [Class] | Advanced Arson Analysis | [] | CCI All Courses | State of California - Department of Justice - Kamala D. Harris Attorney General | Class | https://www.oag.ca.gov/cci/all-courses?order=title&sort=asc | 39/1438042989126.22_20150728002309-00292-ip-10-236-191-2_913022365_0.json |
d421d4e2_ala_D__Harris_Attorney_General__Class | [Class Code] S902 [Class] | ADVANCED CRIME SCENE INVESTIGATION | [] | CCI All Courses | State of California - Department of Justice - Kamala D. Harris Attorney General | Class | https://www.oag.ca.gov/cci/all-courses?order=title&sort=asc | 39/1438042989126.22_20150728002309-00292-ip-10-236-191-2_913022365_0.json |
d421d4e2_ala_D__Harris_Attorney_General__Class | [Class Code] R220 [Class] | Advanced DNA Extraction and Quantification | [] | CCI All Courses | State of California - Department of Justice - Kamala D. Harris Attorney General | Class | https://www.oag.ca.gov/cci/all-courses?order=title&sort=asc | 39/1438042989126.22_20150728002309-00292-ip-10-236-191-2_913022365_0.json |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.